ArticleJournal of inflammation research2025

The Potential of High-Density Lipoprotein as a Predictive Biomarker for Infliximab Efficacy in Crohn's Disease.

Keke Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.